UZEDY (risperidone) extended-release injectable suspension, for subcutaneous use, is indicated for the treatment of schizophrenia in adults. In clinical trials, UZEDY significantly reduced the risk of schizophrenia relapse. 2, 10 UZEDY administers risperidone through copolymer technology under license from MedinCell that allows for absorption …
FBI Reform - fbireform.comFBI Reform - fbireform.com - The News And Times